{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:12:05Z","timestamp":1790223125108,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.ajog.2006.05.012","type":"journal-article","created":{"date-parts":[[2006,6,22]],"date-time":"2006-06-22T07:34:42Z","timestamp":1150961682000},"page":"1311-1319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Oral contraceptives and premenstrual symptoms: Comparison of a 21\/7 and extended regimen"],"prefix":"10.1016","volume":"195","author":[{"given":"Andrea L.","family":"Coffee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kuehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherilyn","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Sulak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2006.05.012_bib1","series-title":"Clinical management guidelines for obstetricians-gynecologists: premenstrual syndrome. ACOG practice bulletin 15","author":"American College of Obstetricians and Gynecologists","year":"2000"},{"key":"10.1016\/j.ajog.2006.05.012_bib2","series-title":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision","first-page":"771","article-title":"Premenstrual dysphoric disorder","year":"2000"},{"issue":"Suppl 3","key":"10.1016\/j.ajog.2006.05.012_bib3","first-page":"1","article-title":"The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD)","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ajog.2006.05.012_bib4","first-page":"1014","article-title":"Severity of premenstrual symptoms in a health maintenance organization population","volume":"99","author":"Sternfeld","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.05.012_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-3999(92)90090-O","article-title":"A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive","volume":"36","author":"Graham","year":"1992","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.ajog.2006.05.012_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(92)90006-F","article-title":"Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations","volume":"46","author":"B\u00e4ckstr\u00f6m","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2006.05.012_bib7","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0002-9378(03)00927-X","article-title":"Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration","volume":"189","author":"Joffe","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.05.012_bib8","first-page":"261","article-title":"Hormone withdrawal symptoms in oral contraceptive users","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.05.012_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0015-0282(99)00205-8","article-title":"Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 \u03bcg) and ethinyl estradiol (15 \u03bcg) on ovarian activity","volume":"72","author":"Sullivan","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2006.05.012_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajog.2004.02.012","article-title":"Manipulation\u00a0of the pill-free interval in oral contraceptive users: the effects on follicular suppression","volume":"190","author":"Schlaff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.05.012_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone\u00a0in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.05.012_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13625180008500387","article-title":"A comparative investigative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel","volume":"5","author":"Foidart","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2006.05.012_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2004.07.010","article-title":"A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 mug on premenstrual symptoms","volume":"71","author":"Sangthawan","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2006.05.012_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2006.05.012_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1185\/03007998709112403","article-title":"A\u00a0double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome","volume":"10","author":"Vellacott","year":"1987","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ajog.2006.05.012_bib16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00016349509021201","article-title":"Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study","volume":"74","author":"Wang","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"Issue 3","key":"10.1016\/j.ajog.2006.05.012_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004695.pub2","article-title":"Continuous or extended cycle vs cyclic use of combined oral contraceptives for contraception","author":"Edelman","year":"2005","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.ajog.2006.05.012_bib18","first-page":"87","article-title":"Recognizing and treating premenstrual dysphoric disorder","volume":"9","author":"Batra","year":"2002","journal-title":"JCOM"},{"key":"10.1016\/j.ajog.2006.05.012_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.02.048","article-title":"Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen","author":"Sulak","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.05.012_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A multicenter, randomized study of an extended cycle oral contraceptive","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2006.05.012_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/ejc.8.3.162.169","article-title":"Use of an oral contraceptive containing drospirenone in an extended regimen","volume":"8","author":"Sillem","year":"2003","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2006.05.012_bib22","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0002-9378(98)70292-3","article-title":"Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval","volume":"179","author":"Killick","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.05.012_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0010-7824(96)00137-0","article-title":"Shorter pill-free interval in combined oral contraceptives decreases follicular development","volume":"54","author":"Spona","year":"1996","journal-title":"Contraception"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937806006144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937806006144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:18:17Z","timestamp":1757585897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937806006144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0002937806006144"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2006.05.012","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral contraceptives and premenstrual symptoms: Comparison of a 21\/7 and extended regimen","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2006.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}